Agile Therapeutics, Inc. revenue breakdown overview

Agile Therapeutics, Inc. revenue for the last year amounted to 19.59 M USD, the most of which — 19.59 M USD — came from its highest performing source at the moment, Transdermal Patch, the year earlier bringing 10.88 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Agile Therapeutics, Inc. 19.59 M USD, and the year before that — 10.88 M USD.